ELAN
Elanco Animal Health, Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$23.49
−0.25%Forward multiples
Based on analyst estimates
- P/E forward
- 19.11x
- P/E 2026E
- 20.72x
- P/E 2027E
- 18.41x
- P/E 2028E
- 16.27x
- P/S forward
- 2.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.78x
- Price / sales
- 2.34x
- Price / cash flow
- 19.02x
Enterprise value
- Enterprise value
- $15.1B
- EV / sales
- 3.01x
- EV / EBITDA
- 19.54x
- EV / EBIT
- 32.74x
- Market cap
- $11.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026